-+ 0.00%
-+ 0.00%
-+ 0.00%

DYNE THERAPEUTICS ANNOUNCES INITIATION OF PHASE 3 FORZETTO TRIAL OF Z-ROSTUDIRSEN IN DUCHENNE MUSCULAR DYSTROPHY (DMD) AHEAD OF PLANNED BLA SUBMISSION FOR U.S. ACCELERATED APPROVAL

Reuters·05/20/2026 11:46:18

Please log in to view news